FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump vows US will strike Iran’s power plants, bridges if Strait of Hormuz is not reopened

Federal judge blocks Trump push to collect race-based admissions data

Scott Jennings Mocks Dems Over Radical ‘No Kings’ Rallies

Kangaroo Escapes Petting Zoo in Feat of Derring-Do, Leads Zookeeper on 3-Day Chase as Heat-Seeking Drone Helps Solve the Case

This Democrat vows to save Nebraska’s ‘Blue Dot.’ Critics say he’s the one putting it at risk

Artemis II astronauts face toilet trouble as they head toward the moon

Breaking: Downed US F-15 Crew Member Rescued After Evading Capture in Iranian Mountains

DHS slams Democrat Sen Chris Van Hollen claim, says illegal alien caused crash while fleeing ICE

Illegal migrant charged in deadly 124 mph chase that killed pregnant teen, unborn child

Massive manhunt underway in New Hampshire town after gunman allegedly wounds police officer, fires on family

Jesse Watters Asks Todd Blanche Point-Blank If He Thinks Bondi Mishandled Epstein Files

Hegseth Says Service Members May Carry Firearms on Military Bases Reversing Dangerous Biden Policy

A de facto pro forma: Why Washington fixated these sessions as the DHS shutdown dragged on through recess

Tom Homan Reveals What’s Next for DOJ After Bondi’s Exit

At least 13 people injured after vehicle slams into Louisiana parade: sheriff’s office

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”